News & Events Press Releases September 15, 2021Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer April 13, 2021Kyverna Therapeutics Announces the Appointment of James Chung, M.D., Ph.D., as Chief Medical Officer January 13, 2020Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences Media Inquiries To learn more about Kyverna’s work developing cell therapy for inflammatory and autoimmune disease, please reach out to us at: media@kyvernatx.com
